“Express Scripts (ESRX) has been reiterated by TheStreet Ratings as a buy with a ratings score of B . The company’s strengths can be seen in multiple areas, such as its robust revenue growth, increase in stock price during the past year, reasonable valuation levels, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.”
,” the firm’s analyst wrote.
TheStreet has also modified their ratings on a number of other services stocks in the few days. The firm reiterated its buy rating on shares of Accenture Plc. Also, TheStreet downgraded shares of FTI Consulting from a buy rating to a hold rating.
Express Scripts traded up 0.09% on Thursday, hitting $57.41. Express Scripts has a 52-week low of $49.79 and a 52-week high of $66.06. The stock’s 50-day moving average is currently $55.04. The company has a market cap of $46.990 billion and a price-to-earnings ratio of 32.72.
A number of other analysts have also recently weighed in on ESRX. Analysts at Oppenheimer reiterated an outperform rating on shares of Express Scripts in a research note to investors on Wednesday, February 20th. They now have a $62.00 price target on the stock, up previously from $60.00. Separately, analysts at Lazard Capital Markets raised their EPS on shares of Express Scripts in a research note to investors on Wednesday, February 20th. They now have a buy rating and a $65.00 price target on the stock. Finally, analysts at Macquarie downgraded shares of Express Scripts from an outperform rating to a neutral rating in a research note to investors on Wednesday, February 20th.
Eighteen analysts have rated the stock with a buy rating, two have given an overweight rating, and five have issued a hold rating to the company’s stock. The stock presently has an average rating of buy and an average target price of $63.55.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.